Cord-blood respiratory syncytial virus antibodies and respiratory health in first 5-years of life.
Mari D. Takashima MEpi,1 Keith Grimwood FRACP MD,1,2 Peter D. Sly FRACP DSc,3,4Stephen B. Lambert MBBS PhD,5 Keith J. Chappell PhD,4,6 Daniel Watterson PhD,4,6Paul Young PhD,4,6 Merci Kusel MBBS PhD7, Barbara Holt PhD7, Patrick Holt PhD7, Robert S. Ware PhD.1
1Menzies Health Institute Queensland and School of Medicine and Dentistry, Griffith University, Southport 4222, Queensland, Australia; 2Departments of Infectious Diseases and Paediatrics, Gold Coast Health, Southport 4215, Queensland, Australia;3Children’s Health and Environment Program, Child Health Research Centre, The University of Queensland, South Brisbane 4101, Queensland, Australia; 4Australian Infectious Diseases Research Centre, The University of Queensland, St Lucia 4072, Queensland, Australia; 5Child Heath Research Centre, The University of Queensland, South Brisbane 4101, Queensland, Australia; 6School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia 4072, Queensland, Australia; 7Telethon Kids Institute, Centre for Child Health Research, University of Western Australia, Nedlands 6009, Western Australia, Australia.
Funding: The Childhood Asthma Study (CAS) was supported by the National Health and Medical Research Council (NHMRC) of Australia (program grants 458513 and 211926, and projects grants 139024 and 110247). The Observational Research in Childhood Infectious Diseases (ORChID) study was supported by the NHMRC (project grant 615700) and a program grant from the Children’s Hospital Foundation Queensland (CHFQ; program grant 50006). The Early Life Lung Function (ELLF) study was supported the NHMRC (project grant 1078660). S.B.L. was the recipient of an NHMRC Early Career Fellowship and a CHFQ Mid-career Fellowship. PDS is a Leadership Fellow (L3) of the NHMRC, Australia.